Nakatsu, Y., Kokubo, H., Bumdelger, B., Yoshizumi, M., Yamamotoya, T., Matsunaga, Y., . . . Asano, T. (2017). The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice. Int J Mol Sci.
Chicago-стиль цитированияNakatsu, Yusuke, et al. "The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic MRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice." Int J Mol Sci 2017.
MLA-цитированиеNakatsu, Yusuke, et al. "The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic MRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice." Int J Mol Sci 2017.